Vakminay Pharma Research Private Limited - Company Profile

It is a business services private limited company based in Saidapet, Tamil Nadu, India, established in 2023.
2023 Saidapet, Tamil Nadu, India Active
Last Updated:
Access Report
About Vakminay Pharma Research Private Limited

Vakminay Pharma Research Private Limited, a active private limited company, was established on 02 June 2023 in Saidapet, Tamil Nadu, India. it holds CIN: U82990TN2023PTC160931. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Lalitha Shankar (Director), Kavya Sharma (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 224, 3Rd, Cross Street, Saidapet, Tamil Nadu, 600096.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U82990TN2023PTC160931

  • Registration Number

    160931

  • Incorporation Date

    02 June 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Vakminay Pharma Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vakminay Pharma Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vakminay Pharma Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Lalitha Shankar Director 02 Jun 2023 Current
Kavya Sharma Director 02 Jun 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vakminay Pharma Research.

Enhance accessibility to Vakminay Pharma Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Vakminay Pharma Research revenue growth over time
Vakminay Pharma Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vakminay Pharma Research?

Unlock access to Vakminay Pharma Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vakminay Pharma Research?

Unlock and access historical data on people associated with Vakminay Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vakminay Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vakminay Pharma Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vakminay Pharma Research
Recent Activity within the Organization
  • Annual General Meeting

    The activity Vakminay Pharma Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Vakminay Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Lalitha Shankar was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kavya Sharma was appointed as a Director was appointed as a Director on 02 Jun 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Company Incorporation

    Vakminay Pharma Research Private Limited was registered on 02 Jun 2023 with Roc Chennai & aged 2 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vakminay Pharma Research Private Limited?

The CIN of Vakminay Pharma Research Private Limited is U82990TN2023PTC160931.

Where is Vakminay Pharma Research Private Limited headquartered?

Vakminay Pharma Research Private Limited is headquartered at 224, 3Rd, Cross Street, Saidapet, Tamil Nadu, 600096.

When was Vakminay Pharma Research Private Limited incorporated?

Vakminay Pharma Research Private Limited was incorporated on 02 June 2023.

Who are the current directors of Vakminay Pharma Research Private Limited?

The current directors of Vakminay Pharma Research Private Limited are

Is Vakminay Pharma Research Private Limited a listed company?

Vakminay Pharma Research Private Limited is unlisted.

What is the capital structure of Vakminay Pharma Research Private Limited?

The authorized capital of Vakminay Pharma Research Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available